2B78:XETRA:XETRA-iShares Healthcare Innovation UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 6.665

Change

+0.06 (+0.88)%

Market Cap

USD 1.14B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-22 )

ETFs Containing 2B78:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.26% 18% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.26% 18% F 24% F
Trailing 12 Months  
Capital Gain -3.05% 14% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.05% 13% F 22% F
Trailing 5 Years  
Capital Gain 18.38% 47% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.38% 47% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain 6.56% 64% D 62% D
Dividend Return 6.56% 62% D 59% D-
Total Return N/A 2% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 22.41% 18% F 30% F
Risk Adjusted Return 29.27% 48% F 50% F
Market Capitalization 1.14B 81% B- 72% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.